CompletedNot Applicable

Impact of Self-tonometry on Glaucoma Treatment Decision.

Sweden133 participantsStarted 2021-05-10

Plain-language summary

Self-tonometry with iCare Home is performed by one hundred patients annually at Sankt Erik's Eye Hospital. The investigators want to evaluate the impact that self-tonometry results have on the clinician's choice of glaucoma treatment. The investigators also want to evaluate how often pressure peaks occur outside the clinic's opening hours.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Diagnosed with POAG (primary open-angle glaucoma), PEX (pseudo-exfoliation glaucoma) or OHT (ocular hypertension) * Difference between patients' and staff's iCare Home® measurements less than 5 mmHg at Baseline * Difference between Goldman Applanation tonometry (GAT) and patient's highest iCare Home® measurements less than 7 mmHg at baseline * Monitoring over at least two days Exclusion Criteria: * More than one measurement with iCare Home® tonometer below 5 mmHg * Missing more than one daily measurement with iCare Home® tonometer

What they're measuring

Clinician's choice of glaucoma treatment

Timeframe: One month

Trial details

NCT IDNCT04888156

SponsorSt. Erik Eye Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-11-30

View on ClinicalTrials.gov More Glaucoma trials